We are excited to announce the expansion of our collaboration with BostonGene. BostonGene is a leading provider of AI-driven molecular and immune profiling solutions. FibroFighters began working with this innovative company about a year and half ago. From the...As part of “Fibrolamellar Cancer Awareness” month as we recognize it, FibroFighters is proud to announce our partnership with Pangea adding yet another critical tool providing better insights into clinical care for Fibrolamellar patients while continuing to gather...Last week, our amazing Medical Director Dr. Paul Kent was a special guest on an episode of TARGET: Cancer Podcast with Dr. Sanjay Juneja, the “OncDoc.” In the discussion, Dr. Kent sheds light on the unique challenges faced by patients with fibrolamellar...The Cardiovascular Learning Network recently featured Dr. Jordan Tasse in a conversation on their podcast. Check out the full conversation at the link here:...xCures partners with FibroFighters to launch a real-time learning platform for Fibrolamellar Hepatocellular...A Temecula father who lost to his son to cancer has teamed with a prominent oncologist in Long Beach to find a cure or treatment for the extremely rare disease.